Pulsenmore (NASDAQ: PLSM) stock dips premarket after announcing a $7.5M private placement to fund its U.S. commercial expansion.

PLSM stock surges over 200% premarket as Pulsenmore partners with Ouma Health to bring FDA-authorized home ultrasound to the U.S.

Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor

Pulsenmore (NASDAQ: PLSM) stock dips premarket after announcing a $7.5M private placement to fund its U.S. commercial expansion.